Bakkal Temi, Y.; Yılmaz Tuğan, B.; Çıtakkul, İ.; Baydar, E.; Karaca, G.; Balcı, S.; Çabuk, D.; Kefeli, U.; Yüksel, N.; Uygun, K.
Structural Retinal and Optic Nerve Changes in Prostate Cancer Patients Receiving Androgen Receptor Pathway Inhibitors: An OCT-Based In Vivo Analysis. Diagnostics 2025, 15, 1682.
https://doi.org/10.3390/diagnostics15131682
AMA Style
Bakkal Temi Y, Yılmaz Tuğan B, Çıtakkul İ, Baydar E, Karaca G, Balcı S, Çabuk D, Kefeli U, Yüksel N, Uygun K.
Structural Retinal and Optic Nerve Changes in Prostate Cancer Patients Receiving Androgen Receptor Pathway Inhibitors: An OCT-Based In Vivo Analysis. Diagnostics. 2025; 15(13):1682.
https://doi.org/10.3390/diagnostics15131682
Chicago/Turabian Style
Bakkal Temi, Yasemin, Büşra Yılmaz Tuğan, İlkay Çıtakkul, Ece Baydar, Gözde Karaca, Sibel Balcı, Devrim Çabuk, Umut Kefeli, Nurşen Yüksel, and Kazım Uygun.
2025. "Structural Retinal and Optic Nerve Changes in Prostate Cancer Patients Receiving Androgen Receptor Pathway Inhibitors: An OCT-Based In Vivo Analysis" Diagnostics 15, no. 13: 1682.
https://doi.org/10.3390/diagnostics15131682
APA Style
Bakkal Temi, Y., Yılmaz Tuğan, B., Çıtakkul, İ., Baydar, E., Karaca, G., Balcı, S., Çabuk, D., Kefeli, U., Yüksel, N., & Uygun, K.
(2025). Structural Retinal and Optic Nerve Changes in Prostate Cancer Patients Receiving Androgen Receptor Pathway Inhibitors: An OCT-Based In Vivo Analysis. Diagnostics, 15(13), 1682.
https://doi.org/10.3390/diagnostics15131682